DR. LAL PATHLABS LTD.
|
Market Cap.(`)
|
23191.69 Cr.
|
P/BV
|
11.59
|
Book Value (`)
|
239.45
|
|
52 Week High/Low ( ` )
|
3654/2201
|
FV/ML
|
10/1
|
P/E(X)
|
47.61
|
|
Book Closure
|
06/06/2025
|
EPS (`)
|
58.27
|
Div Yield (%)
|
0.87
|
(` in Crs.)
You can view the
Consolidated
Cash Flow
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 492.20 | 362.29 | 241.08 | 350.29 | 296.48 |
| | | | | | |
| Net CashFlow From Operating Activities | 568.80 | 535.33 | 456.03 | 446.69 | 398.15 |
| Net Cash Used In Investing Activities | -303.10 | -24.27 | -287.31 | -449.25 | -212.02 |
| Net Cash Used From Financing Activities | -334.00 | -413.86 | -283.18 | 136.45 | -138.56 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -68.30 | 97.20 | -114.46 | 133.90 | 47.58 |
| Cash And Cash Equivalents Begin of Year | 360.90 | 263.73 | 378.20 | 244.30 | 196.72 |
| Cash And Cash Equivalents End Of Year | 292.60 | 360.93 | 263.73 | 378.20 | 244.30 |